Kidney RSS News Feeds

Nephrology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Chanda R et al. – The target BP in transplant recipients is the same as in the CKD population, with no preference for one drug group over another. Unless contraindicated, angiotensin–converting enzyme inhibitors remain the drugs of choice for hypertension in patients with autosomal–dominant polycystic kidney disease, in whom diastolic cardiac dysfunction is a prominent feature.

Today in Hypertension...keeping you current

Role of rho-kinase in the regulation of vascular tone in hypertensive renal transplant recipients
Atherosclerosis, 12/04/09

O-GlcNAcylation Contributes to Augmented Vascular Reactivity Induced by Endothelin
Hypertension, 12/03/09

Blood pressure in children and target-organ damage later in life
Pediatric Nephrology, 12/03/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address